Terms: = Testicular cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
4 results:
1. Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
Cheng W; Li HL; Xi SY; Zhang XF; Zhu Y; Le Xing ; Mo YX; Li MM; Kong FE; Zhu WJ; Chen XG; Cui HQ; Cao ZM; Gong YF; Tang YQ; Zhang Y; Guan XY; Ma NF; Liu M
Nat Commun; 2021 Dec; 12(1):7142. PubMed ID: 34880251
[TBL] [Abstract] [Full Text] [Related]
2. Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.
Li P; Chen X; Qin G; Yue D; Zhang Z; Ping Y; Wang D; Zhao X; Song M; Zhao Q; Li J; Liu S; Wang D; Zhang C; Lian J; Cao L; Li F; Huang L; Wang L; Yang L; Huang J; Li H; Zhang B; Zhang Y
Cancer Immunol Res; 2018 Oct; 6(10):1246-1259. PubMed ID: 30082413
[No Abstract] [Full Text] [Related]
3. Analysis of activin/TGFB-signaling modulators within the normal and dysfunctional adult human testis reveals evidence of altered signaling capacity in a subset of seminomas.
Dias VL; Rajpert-De Meyts E; McLachlan R; Loveland KL
Reproduction; 2009 Nov; 138(5):801-11. PubMed ID: 19661148
[TBL] [Abstract] [Full Text] [Related]
4. Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo.
Gold E; Jetly N; O'Bryan MK; Meachem S; Srinivasan D; Behuria S; Sanchez-Partida LG; Woodruff T; Hedwards S; Wang H; McDougall H; Casey V; Niranjan B; Patella S; Risbridger G
Am J Pathol; 2009 Jan; 174(1):184-95. PubMed ID: 19095948
[TBL] [Abstract] [Full Text] [Related]
